PubRank
Search
About
Joan Blade
Author PubWeight™ 21.02
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
Blood
2011
4.00
2
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.
Blood
2011
2.72
3
Long-term prognostic significance of response in multiple myeloma after stem cell transplantation.
Blood
2011
2.58
4
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.
Hematol J
2003
1.81
5
Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations.
Hematol J
2002
1.72
6
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.
Blood
2008
1.68
7
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.
Blood
2009
1.59
8
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.
Blood
2006
1.51
9
Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study.
Br J Haematol
2013
0.91
10
Management of complications in multiple myeloma.
Semin Hematol
2009
0.88
11
T1 mapping: characterisation of myocardial interstitial space.
Insights Imaging
2014
0.86
12
Myeloablative treatments for multiple myeloma: update of a comparative study of different regimens used in patients from the Spanish registry for transplantation in multiple myeloma.
Leuk Lymphoma
2002
0.81
13
Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopenia.
Eur J Haematol
2011
0.77
14
The future role of thalidomide in multiple myeloma.
Acta Haematol
2005
0.75